Statement of Organization, Functions and Delegations of Authority, 54236-54237 [2011-22261]
Download as PDF
<![CDATA[
jlentini on DSK4TPTVN1PROD with NOTICES
54236
Federal Register / Vol. 76, No. 169 / Wednesday, August 31, 2011 / Notices
since 2006. In light of the threat of an
influenza pandemic it was originally
designed with the goals of bolstering
both international and domestic
pandemic preparedness and response.
The fundamental approach in achieving
these goals has been through the
development of the influenza vaccine
production capabilities of under
resourced nations in the hopes that they
will ultimately be able to produce
vaccines to protect the local, regional,
and international public health. The
program is supported by a collaborative
of U.S. Government agencies,
international organizations, foreign
ministries and/or other foreign
institutions dedicated to achieving these
goals.
The WHO is the only global
organization with the experience and
scientific standing to accomplish the
program goals. It is the recognized
world health authority within the
United Nations system. Similarly, the
liaison and support functions that the
WHO plays within the international
vaccine production capacity building
program cannot be duplicated or
replicated. Through standing
consultation and dialog with its
members states on all aspects of public
health, WHO is the only partner able to
ensure synchronization of building of
production capacity in developing
countries for influenza vaccine with
other pandemic preparedness activities
and with increase of demand for
seasonal influenza immunization.
The WHO’s strong collaborative
relationships with foreign governments,
programmatic support, and familiarity
with international vaccine production
institutions have been and will be
critical to the future viability of this
program. Over the history of the
International Vaccine Production
Capacity Building program, the WHO
has provided unique and invaluable
support to the project. Similarly, the
WHO has also independently funded
other nations/institutions working to
strengthen their influenza vaccine
production capacity; also demonstrating
their commitment to the success of this
program. The WHO represents a key
stakeholder in the implementation of
the program; providing unique
functions, technical and scientific
expertise, and capabilities that no other
organization in the world has.
Additional Information: The agency
program contact is Dr. Rick Bright,
whom can be contacted at (202) 260–
8535 or Rick.Bright@hhs.gov.
(PAHPA), Pub. L. 109–417; and the
Consolidated Appropriations Act, 2010, Pub.
L. 111–117.
Statutory Authority: Section 319L of the
Public Health Service (PHS) Act, 42 U.S.C.
247d–7e as amended by Title IV of the
Pandemic and All-Hazards Preparedness Act
(1) Delete the functional statement for
the Office of Planning, Analysis and
Evaluation (RA5) and replace in its
entirety.
VerDate Mar<15>2010
16:51 Aug 30, 2011
Jkt 223001
Dated: August 25, 2011.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
[FR Doc. 2011–22214 Filed 8–30–11; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at 76 FR 45584–45585
dated July 29, 2011).
This notice reflects organizational
changes to the Health Resources and
Services Administration. Specifically,
this notice updates the Office of
Planning, Analysis and Evaluation
(RA5) functional statement. The update
to the functional statement will better
align functional responsibility with
improved management and
administrative efficiencies and
improved alignment of current liaison
functions and policy processes within
the Office of Planning, Analysis and
Evaluation (RA5).
Chapter RA5—Office of Planning,
Analysis and Evaluation
Section RA5–10, Organization
Delete in its entirety and replace with
the following:
The Office of Policy, Analysis and
Evaluation (RA5) is headed by the
Director, who reports directly to the
Administrator, Health Resources and
Services Administration. The Office of
Planning, Analysis and Evaluation
(RA5) includes the following
components:
(1) Office of the Director (RA5);
(2) Office of Policy Analysis (RA53);
and
(3) Office of Research and Evaluation
(RA56).
Section RA5–20, Functions
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Office of the Director (RA5)
(1) Provides Agency-wide leadership
for policy development, data collection
and management, major analytic
activities, research, and evaluation; (2)
develops HRSA-wide policies; (3)
participates with HRSA organizations in
developing strategic plans for their
component; (4) coordinates the
Agency’s long-term strategic planning
process; (5) conducts and/or guides
analyses, research, and program
evaluation; (6) develops annual
performance plans; (7) analyzes
budgetary data with regard to planning
guidelines; (8) develops and produces
performance reports required under the
Government Performance and
Accountability Report and OMB; (9) as
requested, develops, implements, and
coordinates policy processes for the
Agency for key major cross-cutting
policy issues; (10) facilitates policy
development by maintaining analytic
liaison between the Administrator, other
OPDIVs, Office of the Secretary staff
components, and other Departments on
critical matters involving program
policy undertaken in the Agency; (11)
provides data analyses, graphic
presentations, briefing materials, and
analyses on short notice to support the
immediate needs of the Administrator
and Senior Leadership; (12) conducts
special studies and analyses and/or
provides analytic support and
information to the Administrator and
Senior Leadership needed to support
the Agency’s goals and directions; and
(13) collaborates with the Office of
Operations in the development of
budgets, performance plans, and other
administration reporting requirements.
Office of Policy Analysis (RA53)
(1) Serves as the principal Agency
resource for policy analysis; (2) analyzes
issues arising from legislation, budget
proposals, regulatory actions, and other
program or policy actions; (3) serves as
focal point within HRSA for analysis of
healthcare payment systems and
financing issues; (4) collaborates with
HHS Agencies to examine the impact of
Medicare, Medicaid, and Children’s
Health Insurance Program (CHIP) on
HRSA grantees and safety net providers;
(5) provides Agency leadership
guidance on policy development; (6)
serves as a resource of information and
institutional knowledge for the Agency;
(7) coordinates the Agency’s
participation in Healthy People, and
other Department and Federal
initiatives; (8) coordinates the Agency’s
intergovernmental activities, including:
providing the Administrator with a
single point of contact on all activities
E:\FR\FM\31AUN1.SGM
31AUN1
Federal Register / Vol. 76, No. 169 / Wednesday, August 31, 2011 / Notices
related to important state and local
government, stakeholder association,
and interest group activities;
coordinating Agency cross-Bureau
cooperative agreements and activities
with organizations such as the National
Governors Association, National
Conference of State Legislature,
Association of State and Territorial
Health Officials, National Association of
Counties, and National Association of
County and City Health Officials;
interacting with various commissions
such as the Delta Regional Authority,
Appalachian Regional Commission, and
on the Denali Commission; and serving
as the primary liaison to Department
intergovernmental staff; and (9) serves
as the coordinator for General
Accounting Office reports on HRSA
programs and activities.
Office of Research and Evaluation
(RA56)
(1) Serves as the principal source of
leadership and advice on program
information and research; (2) analyzes
and coordinates the Agency’s need for
information and data for use in the
management and direction of Agency
programs; (3) manages an Agency-wide
information and data group as well as
an Agency-wide research group; (4)
maintains an inventory of HRSA
databases; (5) provides technical
assistance to HRSA staff in database
development, maintenance, analysis,
and distribution; (6) promotes the
availability of HRSA data through Web
sites and other online applications; (7)
conducts, oversees, and fosters high
quality research across HRSA
programmatic interests; (8) develops an
annual research agenda for the Agency;
(9) conducts, leads, and/or participates
with HRSA staff in the development of
research and demonstration projects;
(10) coordinates HRSA participation in
institutional review boards and the
protection of human subjects; (11)
conducts, guides, and/or participates in
major program evaluation efforts and
prepares reports on HRSA program
efficiencies; and (12) manages HRSA
activity related to the Paperwork
Reduction Act, and other OMB policies.
jlentini on DSK4TPTVN1PROD with NOTICES
Section RA5–30, Delegations of
Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
VerDate Mar<15>2010
16:51 Aug 30, 2011
Jkt 223001
Dated: August 19, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011–22261 Filed 8–30–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
54237
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Dated: August 23, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2011–22213 Filed 8–30–11; 8:45 am]
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: October 13–14, 2011.
Time: October 13, 2011, 8:30 a.m. to 3:05
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 2C116, Bethesda, MD 20892.
Time: October 14, 2011, 8:30 a.m. to 2:40
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 2C116, Bethesda, MD 20892.
Contact Person: James E. Balow, MD,
Clinical Director, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Building 10,
Room 9N222, Bethesda, MD 20892–1818,
301–496–4181, jimb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
SPF Colonies.
Date: September 22, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Carol Lambert, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., Dem. 1, Room 1076,
Bethesda, MD 20892, 301–435–0814,
lambert@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: October 25, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, National Institutes
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 76, Number 169 (Wednesday, August 31, 2011)]
[Notices]
[Pages 54236-54237]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22261]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Statement of Organization, Functions and Delegations of Authority
This notice amends part R of the Statement of Organization,
Functions and Delegations of Authority of the Department of Health and
Human Services (HHS), Health Resources and Services Administration
(HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 76
FR 45584-45585 dated July 29, 2011).
This notice reflects organizational changes to the Health Resources
and Services Administration. Specifically, this notice updates the
Office of Planning, Analysis and Evaluation (RA5) functional statement.
The update to the functional statement will better align functional
responsibility with improved management and administrative efficiencies
and improved alignment of current liaison functions and policy
processes within the Office of Planning, Analysis and Evaluation (RA5).
Chapter RA5--Office of Planning, Analysis and Evaluation
Section RA5-10, Organization
Delete in its entirety and replace with the following:
The Office of Policy, Analysis and Evaluation (RA5) is headed by
the Director, who reports directly to the Administrator, Health
Resources and Services Administration. The Office of Planning, Analysis
and Evaluation (RA5) includes the following components:
(1) Office of the Director (RA5);
(2) Office of Policy Analysis (RA53); and
(3) Office of Research and Evaluation (RA56).
Section RA5-20, Functions
(1) Delete the functional statement for the Office of Planning,
Analysis and Evaluation (RA5) and replace in its entirety.
Office of the Director (RA5)
(1) Provides Agency-wide leadership for policy development, data
collection and management, major analytic activities, research, and
evaluation; (2) develops HRSA-wide policies; (3) participates with HRSA
organizations in developing strategic plans for their component; (4)
coordinates the Agency's long-term strategic planning process; (5)
conducts and/or guides analyses, research, and program evaluation; (6)
develops annual performance plans; (7) analyzes budgetary data with
regard to planning guidelines; (8) develops and produces performance
reports required under the Government Performance and Accountability
Report and OMB; (9) as requested, develops, implements, and coordinates
policy processes for the Agency for key major cross-cutting policy
issues; (10) facilitates policy development by maintaining analytic
liaison between the Administrator, other OPDIVs, Office of the
Secretary staff components, and other Departments on critical matters
involving program policy undertaken in the Agency; (11) provides data
analyses, graphic presentations, briefing materials, and analyses on
short notice to support the immediate needs of the Administrator and
Senior Leadership; (12) conducts special studies and analyses and/or
provides analytic support and information to the Administrator and
Senior Leadership needed to support the Agency's goals and directions;
and (13) collaborates with the Office of Operations in the development
of budgets, performance plans, and other administration reporting
requirements.
Office of Policy Analysis (RA53)
(1) Serves as the principal Agency resource for policy analysis;
(2) analyzes issues arising from legislation, budget proposals,
regulatory actions, and other program or policy actions; (3) serves as
focal point within HRSA for analysis of healthcare payment systems and
financing issues; (4) collaborates with HHS Agencies to examine the
impact of Medicare, Medicaid, and Children's Health Insurance Program
(CHIP) on HRSA grantees and safety net providers; (5) provides Agency
leadership guidance on policy development; (6) serves as a resource of
information and institutional knowledge for the Agency; (7) coordinates
the Agency's participation in Healthy People, and other Department and
Federal initiatives; (8) coordinates the Agency's intergovernmental
activities, including: providing the Administrator with a single point
of contact on all activities
[[Page 54237]]
related to important state and local government, stakeholder
association, and interest group activities; coordinating Agency cross-
Bureau cooperative agreements and activities with organizations such as
the National Governors Association, National Conference of State
Legislature, Association of State and Territorial Health Officials,
National Association of Counties, and National Association of County
and City Health Officials; interacting with various commissions such as
the Delta Regional Authority, Appalachian Regional Commission, and on
the Denali Commission; and serving as the primary liaison to Department
intergovernmental staff; and (9) serves as the coordinator for General
Accounting Office reports on HRSA programs and activities.
Office of Research and Evaluation (RA56)
(1) Serves as the principal source of leadership and advice on
program information and research; (2) analyzes and coordinates the
Agency's need for information and data for use in the management and
direction of Agency programs; (3) manages an Agency-wide information
and data group as well as an Agency-wide research group; (4) maintains
an inventory of HRSA databases; (5) provides technical assistance to
HRSA staff in database development, maintenance, analysis, and
distribution; (6) promotes the availability of HRSA data through Web
sites and other online applications; (7) conducts, oversees, and
fosters high quality research across HRSA programmatic interests; (8)
develops an annual research agenda for the Agency; (9) conducts, leads,
and/or participates with HRSA staff in the development of research and
demonstration projects; (10) coordinates HRSA participation in
institutional review boards and the protection of human subjects; (11)
conducts, guides, and/or participates in major program evaluation
efforts and prepares reports on HRSA program efficiencies; and (12)
manages HRSA activity related to the Paperwork Reduction Act, and other
OMB policies.
Section RA5-30, Delegations of Authority
All delegations of authority and re-delegations of authority made
to HRSA officials that were in effect immediately prior to this
reorganization, and that are consistent with this reorganization, shall
continue in effect pending further re-delegation.
This reorganization is effective upon date of signature.
Dated: August 19, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011-22261 Filed 8-30-11; 8:45 am]
BILLING CODE 4165-15-P
